A detailed history of Trv Gp Iv, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Trv Gp Iv, LLC holds 2,343,154 shares of FULC stock, worth $8.34 Million. This represents 5.16% of its overall portfolio holdings.

Number of Shares
2,343,154
Previous 2,343,154 -0.0%
Holding current value
$8.34 Million
Previous $14.5 Million 42.42%
% of portfolio
5.16%
Previous 7.18%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 04, 2019

BUY
$6.64 - $14.89 $15.6 Million - $34.9 Million
2,343,154 New
2,343,154 $15.6 Million

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $185M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Trv Gp Iv, LLC Portfolio

Follow Trv Gp Iv, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trv Gp Iv, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trv Gp Iv, LLC with notifications on news.